Article
Updates on the management of gastrointestinal stromal tumors.
Surgical oncology clinics of North America - 1 Apr 2012
Bamboat Zubin M, Dematteo Ronald P
Abstract excerpt
Despite being the most common sarcoma of the gastrointestinal tract, gastrointestinal stromal tumor (GIST) has been widely recognized as a unique entity for just over a decade. The advent of tyrosine kinase inhibitors has revolutionized the diagnosis and treatment of GIST. Although surgery remains the only chance for cure, multimodal treatment that includes molecular therapy continues to develop. Optimal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
